Delivery Order SPE2DB22D1002-SPE2DB25FLFF1
- Not listed
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed price contract with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 22, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. This firm fixed-price contract, awarded on July 28, 2025, with completion targeted for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector, with a ceiling value of $3,082.67. The contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025, and utilizes firm fixed-price pricing under a non-competitive, non-set-aside arrangement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a $15,413.35 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on July 31, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with a ceiling value of $6,165.34. The award, issued on July 28, 2025, is a firm fixed price delivery order with an ultimate completion date of August 18, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $3,082.67 delivery order contract to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on August 4, 2025, with a completion date of August 25, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Benlysta 200 mg/mL syringes, with a ceiling value of $12,305.60. This is a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a $3,082.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Benlysta 200 mg/mL auto-injector medications. This contract, which is a child award under an existing vehicle, carries an ultimate completion date of September 8, 2025, and involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $3,082.67. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with the company serving as the prime contractor on this delivery...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFF1Delivery Order
The Defense Logistics Agency awarded a delivery order contract valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is competitively awarded. Performance is based in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems. This delivery order demonstrates the company's role within the DLA's comprehensive global pharmaceutical support vehicle, which enables the supply of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The prime IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. Benlysta, a lupus treatment medication, represents the specialized pharmaceutical commodities that AmerisourceBergen routinely delivers under this contractual framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 7/24/25 |